US2005256055A1PendingUtilityA1
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
Est. expiryMay 12, 2024(expired)· nominal 20-yr term from priority
A61K 45/06A61K 38/00
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel compositions and formulations are disclosed that have use as toxicity-reducing agents for various chemotherapeutic agents and as treatment for certain diseases and conditions. The compositions of matter are amino acid and peptide heteroconjugated disulfides of 2-mercaptoethane sulfonate sodium.
Claims
exact text as granted — not AI-modified1 . A compound having the formula: (I) X—S—S—R 1 -R 2 , wherein: R 1 is lower alkylene, optionally substituted by aryl, hydroxy, alkoxy, aryloxy, mercapto, alkylthio or arylthio for a corresponding hydrogen atom; R 2 is sulfonate or phosphonate; X is a sulfur-containing amino acid or a peptide consisting of 2-10 amino acids, optionally substituted by lower alkyl, lower alkenyl, lower alkynyl, aryl, alkoxy, aryloxy, mercapto, alkylthio or hydroxy for a corresponding hydrogen atom; and pharmaceutically acceptable salts and prodrugs thereof.
Join the waitlist — get patent alerts
Track US2005256055A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.